Re: HPV vaccine safety: Cochrane launches urgent investigation into review after criticisms
Nigel Hawke’s report highlights the need for Cochrane assessments to be speedily broadcast. And equally brisk should be the publicity to any question marks on their accuracy. Any tardiness must result in wrong decisions by clinicians. After all the clinicians have to obtain informed consent from patients.
In this particular case, the administration of the vaccine may well have been carried out without full informed consent in some cases.
Does NHS England have any views on the value of HPV vaccine - now that there is a question mark - while Cochrane carries out full review?
Competing interests: No competing interests